Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving ...

An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with ...

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and ...

Shareholders approved a plan to dissolve the robot developer, at one time a well-financed contender to challenge surgical ...

The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges ...

Andrew Aberdale will help expand AiM’s strategic partnership ecosystem, including its recent collaboration with Siemens ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys ...

The supply of the circuit boards needed to fix the devices is significantly constrained, preventing the company from ...